4//SEC Filing
ADAMS ERIC A 4
Accession 0001213900-22-080967
CIK 0001728328other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:50 PM ET
Size
5.8 KB
Accession
0001213900-22-080967
Insider Transaction Report
Form 4
ADAMS ERIC A
DirectorCEO & President10% Owner
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-12-16+15,000→ 28,502 totalExercise: $1.78Exp: 2027-12-15→ Common shares (15,000 underlying)
Footnotes (2)
- [F1]The options were granted on 12/16/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant.
- [F2]On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split.
Documents
Issuer
InMed Pharmaceuticals Inc.
CIK 0001728328
Entity typeother
Related Parties
1- filerCIK 0001817882
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:50 PM ET
- Size
- 5.8 KB